Ground De-Icing Fluid Patents: Leaders, Trends & White Space 2026
- 23.6% concentration at the top. The five leading assignees account for 983 of the 4,165 records in scope, but the remaining ranked leaders still cover a long tail of single- and few-filing entrants.
- Filing has cooled from its 2020 peak. Filings hit 147 in 2020 and fell from 141 in 2021 to 94 in 2024, a 33% drop across that three-year span, before publication lag makes the newest years look thinner than they are.
- Corrosion and biocide chemistry crowd the same IPC classes as the fluids themselves. C23F corrosion-inhibitor claims (14.6%) and A01N biocide claims (6.7%) sit alongside the core C09K materials class (38.7%), showing how much of this space is chemistry borrowed from other fields.
Filing growth compares 2021 (141 records) with 2024 (94) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 4,165 records in scope (CR5), not by the ranked leaders only.
What this landscape covers
This dataset tracks patent families that combine a freezing point depressant — propylene glycol, thickening polymers, or an equivalent anti-icing chemistry — with claims tied to aircraft surfaces, holdover time, residue rehydration, or corrosion inhibition. That pairing separates ground de-icing and anti-icing fluid formulations from the broader universe of antifreeze, food, and pharmaceutical patents that happen to share the same base chemistry.
4,165 records are in scope, spanning 2015 through the 2026 data cut-off. Because publication lags filing by roughly 18 months, the 2025 and 2026 figures are still filling in and should not be read as a decline.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trends and technology composition
Filing volume and IPC composition together show where claim density is concentrated and where activity has actually moved over the past decade.
A 2020 peak followed by a real but overstated pullback
Filings rose from 125 in 2017 to a peak of 147 in 2020, then eased to 141 in 2021 and 94 in 2024 — a 33% decline across that three-year window. The 2025-2026 counts are partial by construction and should not be read alongside the complete years.
Chemistry classes outweigh the aviation-specific ones
C09K (materials for misc. applications) touches 38.7% of the 4,165 records, more than double the next closest class, C23F corrosion and metal removal at 14.6%. A23L food chemistry (13.7%) and A61K medicinal preparations (11.7%) both appear at meaningful share, a reminder that freezing-point-depressant chemistry is claimed across food, pharma and industrial uses as well as aviation ground operations. Because records can carry multiple IPC classes, these shares sum to more than 100% of the record total.
Shares are the percentage of the 4,165 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Ground De Icing Fluids and Operations with Eureka
This page is one run against one query. Ask Eureka your own question about ground de icing fluids and operations and every answer comes back with the patent numbers behind it.
Try EurekaA representative early filing
US5772912A — Environmentally friendly anti-icing
An aqueous, non-electrolytic, non-toxic, biodegradable, single-phase liquid anti-icing or deicing composition for aircraft surfaces, airport pavements and related infrastructure, built on a non-toxic freezing point depressant selected from monohydric or polyhydric alcohols, or their monomethyl/ethyl ether derivatives, mixed with water.Filed by the Administrator of the National Aeronautics and Space Administration; issued 1998-06-30.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20090105605A1 | Apparatus and method for measuring biologic parameters | 530 |
| 2 | US20040242976A1 | Apparatus and method for measuring biologic parameters | 459 |
| 3 | US4983319A | Preparation of low-viscosity improved stable crude oil transport emulsions | 355 |
| 4 | US20080143954A1 | Biologically fit wearable electronics apparatus and methods | 328 |
| 5 | US20150094914A1 | Method and apparatus for biological evaluation | 318 |
| 6 | US20070248238A1 | Biologically fit wearable electronics apparatus and methods | 274 |
| 7 | US6468576B1 | Frozen slush liquid concentrate and method of making same | 258 |
| 8 | US20170119032A1 | High intensity sweeteners | 257 |
| 9 | US20140078462A1 | Biologically fit wearable electronics apparatus | 228 |
| 10 | US6585933B1 | Method and composition for inhibiting corrosion in aqueous systems | 227 |
Citation counts favour older records inside any searched corpus; treat them as a signal of influence rather than current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three patterns stand out once the ranking, the trend and the IPC mix are read together.
Leadership is real but not dominant
The leading assignee holds 291 records and the fifth-ranked holds 109, yet the top five combined still account for less than a quarter of all records in scope. That leaves most of the field to the long tail below tenth place, which holds 72.
Activity has pulled back from its 2020 high
Filings peaked at 147 in 2020 and eased through 2021's 141 to 94 by 2024. That is a genuine three-year decline, not an artefact of publication lag, because 2024 is the last year treated as complete.
Core formulation claims dominate the class mix
C09K materials claims outnumber every other class by a wide margin, with C23F corrosion inhibition and A23L food-grade chemistry the next most populated. The overlap with A61K medicinal preparations (11.7%) and A61F implants (4.2%) shows freezing-point-depressant chemistry is claimed well outside aviation.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to ground de icing fluids and operations, with the prior art for and against each one.
Who is filing, and where the crowded claims sit
The ranked leaders show a moderately concentrated field with a long tail of narrower filers, and recent-year activity has slowed across nearly every named assignee.
A single assignee leads by a wide margin
The top-ranked assignee's 291 records are more than double the fifth-place total of 109, giving it the deepest single portfolio in this dataset even though it does not dominate the field outright.
Recent-year filing has cooled across named assignees
Recent-year momentum figures for the most active assignees range from a handful of records down to zero, with year-over-year declines as steep as -75% to -100%. That pattern is consistent with the broader 2021-2024 pullback rather than specific to any one filer.
Co-filing is limited and concentrated
Only 10 co-assignee pairs appear in this dataset, with the strongest pairing recorded at 10 shared records and the next two at 8 and 6. Co-filing here looks like a handful of long-running individual-inventor relationships rather than a broad collaboration network.
| Assignee | Recent year | YoY |
|---|---|---|
| Firmenich Inc | 2 | -75% |
| Prestone Products Corporation | 1 | -50% |
| FIRMENICH INC | 0 | -100% |
| Texaco Development Corporation | 0 | — |
| Senomyx Inc | 0 | — |
| Chevron U.S.A. Inc | 0 | — |
| ZELTIQ Aesthetics Inc | 0 | -100% |
| Battelle Memorial Institute | 0 | — |
Where to take this analysis
The trend and composition figures point to specific next steps depending on whether you are scoping freedom-to-operate or looking for filing openings.
Check freedom-to-operate against the leader's portfolio
With 291 records concentrated in one assignee's hands, any new formulation claim should be checked against that portfolio's core C09K and C23F filings before drafting.
Explore assignee portfolios in Eureka →Watch the 2025-2026 filings as they publish
Because publication lags filing by about 18 months, the true trajectory of the post-2024 pullback will not be visible for another year or two. Re-check the trend once those years complete.
Track filing trends in Eureka →Map the under-claimed branches before committing R&D spend
Residue rehydration, holdover-time indicators and biocide co-formulations show lighter claim density than the core freezing-point-depressant chemistry. These are worth scoping first.
Run a white-space search in Eureka →Common questions about ground de-icing fluid patents
Within this dataset of 4,165 records, filing is moderately concentrated: the leading assignee holds 291 records, and the top five combined account for 983 records, or 23.6% of all records in scope. That leaves more than three-quarters of the field spread across a long tail of smaller filers, so no single company controls the space outright. Anyone assessing freedom-to-operate should still check the leader's core claims first, since its portfolio is more than double the size of the fifth-ranked filer's.
Filings peaked at 147 in 2020, then declined from 141 in 2021 to 94 in 2024, a 33% drop over that three-year span. That is a genuine slowdown based on complete-year data, not an artefact of reporting delay. Figures for 2025 and 2026 are still partial because publication lags filing by roughly 18 months, so they should not be read as evidence of a further decline.
The dominant class is C09K, materials for miscellaneous applications, appearing in 38.7% of the 4,165 records in scope. Corrosion and metal removal chemistry (C23F) follows at 14.6%, with food chemistry (A23L, 13.7%) and medicinal preparations (A61K, 11.7%) also present at meaningful levels. Because a single record can carry several IPC classes, these percentages sum to more than 100% of the record total and should be read individually, not added together.
US5772912A, filed by NASA's Administrator and issued in 1998, claims an aqueous, non-electrolytic, biodegradable, single-phase liquid anti-icing or deicing composition built on a non-toxic freezing point depressant drawn from a defined list of monohydric and polyhydric alcohols and their ether derivatives, applied to aircraft and related infrastructure surfaces. It is a formulation-and-use patent rather than a platform patent, so it constrains compositions that fall within its specific alcohol and mixture limitations rather than the entire anti-icing fluid category. A new formulation using a freezing point depressant outside that defined alcohol list, or combined with claim elements this patent does not cover, would sit outside its scope, though a formal claim chart is the only reliable way to confirm that for a specific composition.
The IPC composition shows heavy claim density in core materials chemistry (C09K) and corrosion inhibition (C23F), but comparatively lighter coverage in areas like residue rehydration, holdover-time indicator chemistry, and biocide-freezing depressant co-formulations. These adjacent branches sit next to the crowded core claims without being as densely occupied themselves. That pattern suggests room for narrower, application-specific claims in those branches, though any specific opportunity still needs a dedicated freedom-to-operate search before committing R&D spend.
Research Ground De Icing Fluids and Operations in depth with Eureka
Go past this page: query the whole ground de icing fluids and operations corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.